APOTHEEK DE VYLDER
ActiveSummary
APOTHEEK DE VYLDER has been active since 1993 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €346,210 and a net result of €24,541. Equity has been stable since 2018 (±1.3% per year). Its solvency ranks better than 79% of 5,039 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active since 20-12-1993 Normal situation
- Activity
- Retail sale of pharmaceutical products NACE 47730
- Joint committee
- 313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
- Establishment unit
- 2.068.134.030 3570 Alken, since 12-09-1994
- Financial year end
- 31 December
- Peppol
- Reachable since 23-10-2025
Board and ownership
- Invisio BVDirector · since 31-07-2020
- MEES MANAGEMENT APOTHEEK BVDirector · since 31-07-2020
- MEES MANAGEMENT APOTHEEK100%2025 annual accounts of MEES MANAGEMENT APOTHEEK
- Holdings
- Shares in 1 company GEPLUS
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €283,154
- ▼ 1.6%
- Turnover
- ≈ €1.0m
- estimated
- Profit
- €24,541
- ▼ 21.6%
- Equity
- €346,210
- ▼ 60.8%
- Total assets
- €523,721
- ▼ 51.7%
- Employees on 31-12-2025
- 4
- =
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.54, cash €112,996Founded in 1993Equity €346,210 (66.1% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 78% of them on solvency, 69% on liquidity, 60% on profitability and 9% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 23 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as APOTHEEK DE VYLDER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €491,000 and €562,000, founded between 1986 and 1994.
| Company | Total assets | Gross margin |
|---|---|---|
| APOTHEEK DE VYLDER Alken | €523,721 | €283,154 |
| PHARMACIE MANDRAGORE Quaregnon | €532,438 | €232,567 |
| APOTHEEK DE RAM Grobbendonk | €547,206 | €296,260 |
| PHARMACIE E. DOZOT Andenne | €491,246 | €293,770 |
| STRAGIER Ath | €562,496 | €298,584 |
| APOTHEEK CANDIDE JACOBS De Haan | €515,835 | €238,048 |
| PHARMACIE HUART Durbuy | €509,185 | €257,412 |
Key facts about APOTHEEK DE VYLDER
- What is the company number of APOTHEEK DE VYLDER?
- The company number of APOTHEEK DE VYLDER is 0451.529.852. The VAT number is the same number with BE in front: BE 0451.529.852.
- Where is APOTHEEK DE VYLDER based?
- The registered office is at Eduard Dompasstraat 41, 3570 Alken.Company details
- What does APOTHEEK DE VYLDER do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of APOTHEEK DE VYLDER?
- The legal form of APOTHEEK DE VYLDER is Public limited company (NV).
- When was APOTHEEK DE VYLDER founded?
- APOTHEEK DE VYLDER was founded on 20-12-1993.
- Is APOTHEEK DE VYLDER still active?
- Yes, APOTHEEK DE VYLDER is an active enterprise in the KBO register.
- How many employees does APOTHEEK DE VYLDER have?
- APOTHEEK DE VYLDER had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does APOTHEEK DE VYLDER fall under?
- In its 2025 annual accounts, APOTHEEK DE VYLDER states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
- What is the turnover of APOTHEEK DE VYLDER?
- The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €283,154 and 47 comparable companies (NACE 477). It probably lies between €800,000 and €1.7m.
- Is APOTHEEK DE VYLDER profitable?
- In financial year 2025, APOTHEEK DE VYLDER made a profit of €24,541.
- Where can I find the annual accounts of APOTHEEK DE VYLDER?
- APOTHEEK DE VYLDER filed 32 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APOTHEEK DE VYLDER due?
- APOTHEEK DE VYLDER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.